LumiraDx Ltd - Company Profile
Powered by
All the data and insights you need on LumiraDx Ltd in one report.
- Save hours of research time and resources with
our up-to-date LumiraDx Ltd Strategy Report
- Understand LumiraDx Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
LumiraDx Ltd (LumiraDx), is a next-generation point of care (PoC) diagnostic company that provides tests to screen novel coronavirus diseases (COVID-19) and other diseases to improve health outcomes for patients. Focus on innovation, manufacturing capabilities, and decrease in trade receivables are its strengths even as decrease in business performance could hamper its operational capabilities. The company could benefit from regulatory approvals, the unmet need for COVID-19 diagnosis, and global diagnostic imaging market. However, intense competition, rapid technological changes, and government regulations could affect the company's business, operating results and financial condition.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer